Abbott India MD Vivek Kamath resigns
His resignation would be effective from March 18, 2024
His resignation would be effective from March 18, 2024
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.
Zidavi is recommended by the Infectious Disease Society of America
Subscribe To Our Newsletter & Stay Updated